Chronic Thoracic Aortic Dissection: How to Treat, When to Intervene.
Panteleimon E PapakonstantinouDimitra BeniaDimitrios PolyzosKonstantinos PapakonstantinouFilippos-Paschalis RorrisFotios ToulgaridisKonstantinos ManousiadisSotirios XydonasAntonios SiderisPublished in: Life (Basel, Switzerland) (2022)
Thoracic aortic dissection (AD) is associated with increased morbidity and mortality. Acute aortic syndrome is the first presentation of the disease in most cases. While acute AD management follows concrete guidelines because of its urgent and life-threatening nature, chronic AD is usually overlooked, although it concerns a wide spectrum of patients surviving an acute event. Acute AD survivors ultimately enter a chronic aortic disease course. Patients with chronic thoracic AD (CTAD) require lifelong surveillance and a proportion of them may present with symptoms and late complications demanding further surgical or endovascular treatment. However, the available data concerning the management of CTAD is sparse in the literature. The management of patients with CTAD is challenging as far as determining the best medical therapy and deciding on intervention are concerned. Until recently, there were no guidelines or recommendations for imaging surveillance in patients with chronic AD. The diagnostic methods for imaging aortic diseases have been improved, while the data on new endovascular and surgical approaches has increased significantly. In this review, we summarize the current evidence in the diagnosis and management of CTAD and the latest recommendations for the surgical/endovascular aortic repair of CTAD.
Keyphrases
- aortic dissection
- clinical practice
- spinal cord
- high resolution
- endovascular treatment
- end stage renal disease
- public health
- healthcare
- electronic health record
- chronic kidney disease
- drug induced
- systematic review
- big data
- heart failure
- prognostic factors
- case report
- physical activity
- stem cells
- machine learning
- left ventricular
- coronary artery
- data analysis
- spinal cord injury
- mesenchymal stem cells
- depressive symptoms
- patient reported outcomes
- hepatitis b virus
- atrial fibrillation
- smoking cessation